DE60227922D1 - Säurelösliche Proteine aus Casein-Micellen - Google Patents

Säurelösliche Proteine aus Casein-Micellen

Info

Publication number
DE60227922D1
DE60227922D1 DE60227922T DE60227922T DE60227922D1 DE 60227922 D1 DE60227922 D1 DE 60227922D1 DE 60227922 T DE60227922 T DE 60227922T DE 60227922 T DE60227922 T DE 60227922T DE 60227922 D1 DE60227922 D1 DE 60227922D1
Authority
DE
Germany
Prior art keywords
casein
acid
micellar casein
soluble proteins
soluble protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60227922T
Other languages
English (en)
Inventor
Sandrine Gremlich
Lionel Bovetto
Catherine Mace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA filed Critical Nestec SA
Application granted granted Critical
Publication of DE60227922D1 publication Critical patent/DE60227922D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
DE60227922T 2002-05-27 2002-05-27 Säurelösliche Proteine aus Casein-Micellen Expired - Lifetime DE60227922D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02077076A EP1367065B1 (de) 2002-05-27 2002-05-27 Säurelösliche Proteine aus Casein-Micellen

Publications (1)

Publication Number Publication Date
DE60227922D1 true DE60227922D1 (de) 2008-09-11

Family

ID=29414783

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60227922T Expired - Lifetime DE60227922D1 (de) 2002-05-27 2002-05-27 Säurelösliche Proteine aus Casein-Micellen

Country Status (3)

Country Link
EP (1) EP1367065B1 (de)
AT (1) ATE402955T1 (de)
DE (1) DE60227922D1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007525404A (ja) 2003-08-30 2007-09-06 ネステク ソシエテ アノニム ミセルカゼインの酸可溶性蛋白質
DK1831361T3 (da) 2004-12-23 2012-05-14 Campina Nederland Holding Bv Proteinhydrolysat beriget med peptider, som inhiberer DPP-IV, og deres anvendelse
US20090131316A1 (en) 2005-09-30 2009-05-21 Morinaga Milk Industry Co., Ltd. Glucagon-like peptide-1 secretagogue, glucagon-like peptide-1 secretagogue food or drink, inhibitor of postprandial rise in blood glucose, and inhibitory food or drink of postprandial rise in blood glucose
JP2009517464A (ja) * 2005-11-30 2009-04-30 カンピーナ ネーダーランド ホールディング ビー.ブイ. グルカゴン様ペプチド1の活性を増強するタンパク質加水分解物の使用
EP2286679A1 (de) * 2009-08-19 2011-02-23 Nestec S.A. Proteosepepton- und Lipaseaktivität
US20190381128A1 (en) * 2017-03-03 2019-12-19 Morinaga Milk Industry Co., Ltd. GLP-1 Secretagogue and Composition
JP7146676B2 (ja) * 2019-03-15 2022-10-04 日清食品ホールディングス株式会社 分泌促進能評価試験方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673374A1 (fr) * 1991-03-01 1992-09-04 Oreal Composition cosmetique contenant comme ingredient actif un peptide a activite opiouide.
US6268487B1 (en) * 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes

Also Published As

Publication number Publication date
EP1367065A1 (de) 2003-12-03
ATE402955T1 (de) 2008-08-15
EP1367065B1 (de) 2008-07-30

Similar Documents

Publication Publication Date Title
TW200635604A (en) Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)
Segura-Campos et al. Bioavailability of bioactive peptides
Zhao et al. Novel peptide with a specific calcium-binding capacity from whey protein hydrolysate and the possible chelating mode
DE60121280D1 (de) Verfahren zur Entaromatisierung von sojahaltigen Materialen
Tulipano et al. Characterisation of the potential of β-lactoglobulin and α-lactalbumin as sources of bioactive peptides affecting incretin function: In silico and in vitro comparative studies
DE60330767D1 (de) Ferritinfusionsproteine zur verwendung für impfstoffe und andere anwendungen
WO2002066511A3 (en) Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
JP2004521653A5 (de)
EP2433506A3 (de) Altersangepasstes Ernährungssystem für Kinder
RU2010141720A (ru) Жидкая энтеральная питательная композиция с высоким содержанием белка
WO2009052396A3 (en) Novel process for solubilizing protein from a proteinaceous material and compositions thereof
WO2008039483A3 (en) Modified self-assembling peptides
HUP0200292A2 (hu) Táplálék-kompozíció éretlen emlősök számára, speciális gyomor- és bélrendszeri éréshez
DE60227922D1 (de) Säurelösliche Proteine aus Casein-Micellen
WO2006052821A3 (en) Compositions and methods for treatment of protein misfolding and protein aggregation diseases
EP2039367A4 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
WO2002024883A3 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
JP2011517450A5 (de)
JP2005213260A (ja) プロテアーゼ阻害剤
BR0318443A (pt) proteìnas solúveis em ácido de caseìna micelar
ATE447612T1 (de) Fluoreszenzproteine
Soltani et al. Functional properties and nutritional quality of whey proteins
WO2002062370A3 (en) Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
ATE400581T1 (de) Peptid-antioxidantien aus sojaproteinen
DK1602721T3 (da) Phospholipase A SB 2 /SB stammende fra Koji-skimmelsvamp

Legal Events

Date Code Title Description
8364 No opposition during term of opposition